A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing Chemotherapy
Condition: Anemia Interventions: Drug: Darbepoetin alfa; Drug: Placebo Sponsor: Amgen Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials